Business Ebola in U.S: Pharmaceutical Companies With Potential Cure Record Jump in Stocks

L

LequteMan

Guest
Stocks of several pharmaceutical companies with potential Ebola treatments jumped in extended trade on Tuesday after the U.S. Centers for Disease Control and Prevention confirmed the first case of the virus diagnosed at an hospital in Dallas.

U.S.-listed shares of Tekmira Pharmaceuticals (TKMR.O) jumped 20.6 percent to $25.50, BioCryst Pharmaceuticals (BCRX.O) surged 14.5 percent to $11.20 while Sarepta Therapeutics (SRPT.O) climbed 8.2 percent to $22.83 Reuters says.

#America #Ebola #US #Tekmira #Reuters

vaccine-Ebola1.jpg
 
Back
Top